Search

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

… Wednesday, September 25, 2013 Summary A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis. A new imaging approach being investigated by Memorial Sloan Kettering researchers

A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.

… Wednesday, August 23, 2023 Highlights New research shows how a key immune pathway — the STING pathway — which normally defends the body against viruses and cancer, actually dampens immune responses and helps cancer spread. When STING is persistently activated, it leads to desensitization and a rewiring

In honor of Minority Cancer Awareness Month, Dr. Brown shared information about cancer disparities, the importance of cancer screening, and MSK's health equity work.

… Friday, April 30, 2021 In honor of Minority Cancer Awareness Month, MSK’s Chief Health Equity Officer Dr. Carol Brown spoke with NY1 reporter Ruschell Boone on April 29 about cancer health disparities , the role fear plays in cancer screening hesitancy, and the importance of not putting off cancer screening

Twelve students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 14.

… Thursday, May 8, 2014 Twelve students at the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences have successfully defended their dissertations. As part of Memorial Sloan Kettering’s 35th annual academic convocation on May 14, Gerstner Sloan Kettering will award PhD degrees to Minna Balbas,

Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.

… Friday, May 15, 2020 Summary Hundreds of Memorial Sloan Kettering employees who have recovered from COVID-19 have stepped forward to donate their plasma to treat patients through a clinical trial led by Esperanza Papadopoulos. As the world struggles with the epic challenge of the COVID-19 pandemic, employees

Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.

… Thursday, October 12, 2017 The largest retrospective study ever done to assess the impact of hepatic arterial infusion (HAI) chemotherapy on survival outcomes in people with colorectal cancer with liver metastases has shown that the addition of HAI extends survival by almost two years . The results of

Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of the curriculum.

… Tuesday, October 14, 2014 Gerstner Sloan Kettering Graduate School student stipends are supported by a variety of sources including philanthropic fellowships. Annually, GSK awards fellowships to two second-year students and six first-year students based on academic achievement in different elements of

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.

… Sunday, March 23, 2008 Research led by investigators at Memorial Sloan Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice. The study’s results are published in the March 23 online edition

Dr. Offodile will serve as MSK’s “futurist,” leading strategy efforts and care transformation initiatives at MSK by continuing to develop the core infrastructure, management systems, and processes for enterprise strategy and business development.

… Monday, April 24, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced that Anaeze Offodile II, MD, MPH , will join the institution as Chief Strategy Officer (CSO) on May 1. Dr. Offodile — a double board-certified physician with clinical expertise in oncologic reconstruction, a health services

Pexidartinib is the first drug approved specifically to treat tenosynovial giant cell tumor.

… Monday, August 5, 2019 Summary Pexidartinib is the first drug approved specifically to treat the rare joint tumor tenosynovial giant cell tumor, which is also known as pigmented villonodular synovitis. On August 2, the US Food and Drug Administration announced that it had approved pexidartinib (Turalio